US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

As health officials report a surge of winter viruses, health experts are warning that heart disease symptoms can sometimes ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

Pregnant women in the Northern Territory (NT) can now receive the respiratory syncytial virus (RSV) vaccine for free under the National Immunisation ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a "quad-demic." Here what you can do.

Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter; it’s a combination of four ...

Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...

Flu is a viral infection affecting the nose, throat and lungs, mostly during the winter months. It is far worse than an ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary ... period with a higher AUC implying a more intense infection. The trial involved 114 healthy adults who ...